These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 7056841

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA, Libbey NP, London MR, Pono L, Abuelo JG.
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [Abstract] [Full Text] [Related]

  • 3. Use of bone mineral content determination in the evaluation of osteodystrophy among hemodialysis patients.
    Heaf JG, Nielsen LP, Mogensen NB.
    Nephron; 1983 Feb; 35(2):103-7. PubMed ID: 6621754
    [Abstract] [Full Text] [Related]

  • 4. [A study using nondecalcified bone biopsy of the incidence and presentation forms of renal osteodystrophy].
    Lorenzo Sellares V, Torres Ramírez A, Hernández Marrero D, Rodríguez Pérez J, González Posada J, Losada Cabrera M, Maceira Cruz B, Hernández Nieto L.
    Med Clin (Barc); 1991 Apr 20; 96(15):561-5. PubMed ID: 2051811
    [Abstract] [Full Text] [Related]

  • 5. Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy.
    Andress DL, Maloney NA, Coburn JW, Endres DB, Sherrard DJ.
    J Clin Endocrinol Metab; 1987 Jul 20; 65(1):11-6. PubMed ID: 3584392
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Review: Renal osteodystrophy--pathogenesis and treatment.
    Cushner HM, Adams ND.
    Am J Med Sci; 1986 Apr 20; 291(4):264-75. PubMed ID: 3518448
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Does strict phosphorus control precipitate renal osteomalacia?
    Delmez JA, Fallon MD, Harter HR, Hruska KA, Slatopolsky E, Teitelbaum SL.
    J Clin Endocrinol Metab; 1986 Apr 20; 62(4):747-52. PubMed ID: 3949954
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia.
    Andress D, Felsenfeld AJ, Voigts A, Llach F.
    Kidney Int; 1983 Sep 20; 24(3):364-70. PubMed ID: 6645210
    [Abstract] [Full Text] [Related]

  • 12. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C, Armas JR, Palma A.
    Nefrologia; 2001 Sep 20; 21(2):174-81. PubMed ID: 11464651
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure.
    Dunstan CR, Evans RA, Hills E, Wong SY, Alfrey AC.
    Calcif Tissue Int; 1984 Mar 20; 36(2):133-8. PubMed ID: 6430496
    [Abstract] [Full Text] [Related]

  • 16. Renal osteodystrophy in CAPD.
    Hutchison AJ, Freemont AJ, Lumb GA, Gokal R.
    Adv Perit Dial; 1991 Mar 20; 7():237-9. PubMed ID: 1680434
    [Abstract] [Full Text] [Related]

  • 17. Bone disease in long-term hemodialysis patients with low dialysate aluminium.
    Grekas DM, Ellis HA, Ward MK, Martin AM, Parkinson I, Kerr DN.
    Uremia Invest; 1984 Mar 20; 8(1):9-15. PubMed ID: 6437038
    [Abstract] [Full Text] [Related]

  • 18. Elevated bone aluminum and suppressed parathyroid hormone levels in hypercalcemic dialysis patients.
    Piraino B, Chen T, Puschett JB.
    Am J Nephrol; 1989 Mar 20; 9(3):190-7. PubMed ID: 2757078
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.